S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
Critical asset just had biggest fall on record (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
Critical asset just had biggest fall on record (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
Critical asset just had biggest fall on record (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
Critical asset just had biggest fall on record (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024

Ligand Pharmaceuticals (LGND) Short Interest Ratio & Short Volume

$74.42
-1.45 (-1.91%)
(As of 02/26/2024 ET)

Ligand Pharmaceuticals Short Interest Data

Current Short Volume
929,800 shares
Previous Short Volume
920,700 shares
Change Vs. Previous Month
+0.99%
Dollar Volume Sold Short
$67.97 million
Short Interest Ratio / Days to Cover
8.1
Last Record Date
January 31, 2024
Outstanding Shares
17,350,000 shares
Float Size
16,410,000 shares
Short Percent of Float
5.67%
Today's Trading Volume
91,797 shares
Average Trading Volume
107,118 shares
Today's Volume Vs. Average
86%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Ligand Pharmaceuticals ?

Sign up to receive the latest short interest report for Ligand Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

LGND Short Interest Over Time

LGND Days to Cover Over Time

LGND Percentage of Float Shorted Over Time

Ligand Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/2024929,800 shares $67.97 million +1.0%5.7%8.1 $73.10
1/15/2024920,700 shares $66.84 million +2.2%6.9%8.2 $72.60
12/31/2023900,800 shares $64.34 million +0.8%5.5%8.2 $71.42
12/15/2023893,600 shares $60.18 million -1.7%5.5%8.1 $67.35
11/30/2023909,100 shares $53.01 million -2.3%5.5%8.8 $58.31
11/15/2023930,200 shares $52.54 million +6.1%5.7%9.2 $56.48
10/31/2023876,400 shares $45.83 million +3.8%5.4%8.8 $52.29
10/15/2023844,700 shares $46.45 million +2.5%5.2%8.8 $54.99
9/30/2023824,100 shares $49.38 million -0.1%5.1%8.4 $59.92
9/15/2023825,000 shares $51.13 million -6.2%5.1%8.8 $61.98
8/31/2023879,200 shares $57.82 million +4.6%5.4%9.1 $65.77
8/15/2023840,500 shares $56.81 million +4.3%5.2%8.6 $67.59
7/31/2023805,800 shares $53.93 million -3.4%5.0%8.2 $66.93
7/15/2023834,300 shares $56.61 million -1.4%5.1%8.4 $67.85
6/30/2023846,200 shares $61.01 million +4.0%5.2%8.6 $72.10
6/15/2023814,000 shares $64.30 million -1.6%5.0%7.8 $78.99
5/31/2023827,100 shares $57.96 million +1.3%5.1%7.9 $70.08
5/15/2023816,400 shares $63.34 million +0.7%5.0%7.2 $77.59
4/30/2023811,100 shares $61.93 million +5.1%5.1%7 $76.35
4/15/2023771,800 shares $57.38 million -1.0%4.8%6.6 $74.34
3/31/2023779,200 shares $57.32 million -13.5%4.9%6.5 $73.56
3/15/2023900,500 shares $64.48 million +7.5%5.6%7.1 $71.61
2/28/2023838,100 shares $60.46 million +2.5%5.2%5.1 $72.14
2/15/2023817,900 shares $59.69 million +1.5%5.1%4.8 $72.98
1/31/2023806,000 shares $56.18 million +0.1%5.1%4.6 $69.70
1/15/2023805,000 shares $57.38 million +1.5%5.1%4.1 $71.28
12/30/2022792,800 shares $52.96 million -8.4%5.0%4.1 $66.80
12/15/2022865,800 shares $53.81 million +13.0%5.5%4.4 $62.15
11/30/2022766,100 shares $55.85 million -2.3%4.8%4.6 $72.90
11/15/2022784,100 shares $61.99 million +6.6%4.9%5 $79.06
10/31/2022735,400 shares $64.46 million -0.3%4.6%5 $87.65
10/15/2022737,800 shares $66.03 million -6.7%4.6%6 $89.49
9/30/2022790,600 shares $68.08 million -5.1%5.0%6.6 $86.11
9/15/2022833,000 shares $75.08 million +3.1%5.2%7 $90.13
8/31/2022808,200 shares $74.67 million -3.7%5.1%6.6 $92.39
8/15/2022839,000 shares $90.03 million -3.2%5.3%6.8 $107.31
7/31/2022866,700 shares $79.76 million -0.8%5.4%6.5 $92.03
7/15/2022873,600 shares $82.58 million -3.6%5.4%6 $94.53
6/30/2022905,800 shares $80.82 million -0.2%5.6%6 $89.22
6/15/2022907,900 shares $71.80 million -0.6%N/A5.7 $79.08
Critical asset just had biggest fall on record (Ad)

What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."

Full details and steps to take here.













LGND Short Interest - Frequently Asked Questions

What is Ligand Pharmaceuticals' current short interest?

Short interest is the volume of Ligand Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of January 31st, investors have sold 929,800 shares of LGND short. 5.67% of Ligand Pharmaceuticals' shares are currently sold short. Learn More on Ligand Pharmaceuticals' current short interest.

What is a good short interest ratio for Ligand Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LGND shares currently have a short interest ratio of 8.0. Learn More on Ligand Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Ligand Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Ligand Pharmaceuticals: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Ligand Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.67% of Ligand Pharmaceuticals' floating shares are currently sold short.

Is Ligand Pharmaceuticals' short interest increasing or decreasing?

Ligand Pharmaceuticals saw a increase in short interest in the month of January. As of January 31st, there was short interest totaling 929,800 shares, an increase of 1.0% from the previous total of 920,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Ligand Pharmaceuticals' float size?

Ligand Pharmaceuticals currently has issued a total of 17,350,000 shares. Some of Ligand Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Ligand Pharmaceuticals currently has a public float of 16,410,000 shares.

How does Ligand Pharmaceuticals' short interest compare to its competitors?

5.67% of Ligand Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Ligand Pharmaceuticals: Geron Co. (7.49%), Innoviva, Inc. (19.24%), MannKind Co. (12.98%), Dynavax Technologies Co. (10.97%), OPKO Health, Inc. (23.70%), Lexicon Pharmaceuticals, Inc. (9.40%), COMPASS Pathways plc (5.74%), Travere Therapeutics, Inc. (13.05%), Nurix Therapeutics, Inc. (16.52%), Shattuck Labs, Inc. (1.76%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short Ligand Pharmaceuticals stock?

Short selling LGND is an investing strategy that aims to generate trading profit from Ligand Pharmaceuticals as its price is falling. LGND shares are trading down $1.45 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Ligand Pharmaceuticals?

A short squeeze for Ligand Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LGND, which in turn drives the price of the stock up even further.

How often is Ligand Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LGND, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:LGND) was last updated on 2/27/2024 by MarketBeat.com Staff

From Our Partners